Topic
Series E
1 story tagged Series E, newest first.
Sep 23, 2026, 7:31 PMAI, Biotech and Health
Enveda Raises $311M at $2B Valuation for Nature Derived AI Drugs
Enveda raises $311 million at a $2 billion valuation to advance AI discovered medicines from plants and microbes, including candidates now in human trials.
DateSectionHeadlineSource